🧪Trial version — For internal lab review only. Not for clinical or production use.
VaxIQ/Japanese Encephalitis
← Back to VaxIQ

Japanese Encephalitis

Japanese Encephalitis Vaccine (IXIARO)

Tier 2 · ExtendedVaccineCuration in progress

Platform: Inactivated viral (Vero cell-derived)

Vaccine that protects against Japanese encephalitis, a mosquito-borne viral brain infection prevalent in Asia and the Western Pacific.

PRNT50JEflavivirusAsiatravel

Immunology Sections

Curated section analysis in progress

Structured immunology sections — mechanism, immune response, molecular signatures, correlates of protection, and more — are being prepared by the Precision Vaccines Program team. In the meantime, verified references and live literature from PubMed, Semantic Scholar, and Wikipedia are available below.

MechanismImmune ResponseMolecular & Immune SignaturesCorrelates of ProtectionOpen QuestionsImmunogenicitySafetyInfection Immunology

Wikipedia Overview

Full article ↗
Japanese encephalitis vaccine

Japanese encephalitis vaccine is a vaccine that protects against Japanese encephalitis. The vaccines are more than 90% effective. The duration of protection with the vaccine is not clear but its effectiveness appears to decrease over time. Doses are given either by injection into a muscle or just under the skin.

PubMed Literature

Search PubMed ↗

No PubMed results retrieved.

Semantic Scholar

Search S2 ↗

No Semantic Scholar results retrieved.